Cyril Schiever
Cyril Schiever is Senior Vice President and President of MidEurope Region for MSD, leading a $2.7 billion business in a region of 25 countries and over 2000 employees. Prior to this role, Cyril was SVP and Managing director of MSD in France, successfully leading a business of $1.5 billion. Cyril was a Board member of the LEEM (industry association) and was elected President of the LEEM legal commission in December 2014. He was also Secretary of Agipharm (French association of US pharmaceutical companies). Prior to that, Cyril led MSD's subsidiary in Canada. Cyril’s entire career has been international, first with …
Cyril Schiever is Senior Vice President and President of MidEurope Region for MSD, leading a $2.7 billion business in a region of 25 countries and over 2000 employees.
Prior to this role, Cyril was SVP and Managing director of MSD in France, successfully leading a business of $1.5 billion. Cyril was a Board member of the LEEM (industry association) and was elected President of the LEEM legal commission in December 2014. He was also Secretary of Agipharm (French association of US pharmaceutical companies).
Prior to that, Cyril led MSD's subsidiary in Canada. Cyril’s entire career has been international, first with Sanofi, then Schering-Plough and MSD. He held several executive roles in different geographies.
Cyril is a French national and holds an MBA and a master’s diploma in international business and marketing from the University of Paris-Dauphine.
See more
Prior to this role, Cyril was SVP and Managing director of MSD in France, successfully leading a business of $1.5 billion. Cyril was a Board member of the LEEM (industry association) and was elected President of the LEEM legal commission in December 2014. He was also Secretary of Agipharm (French association of US pharmaceutical companies).
Prior to that, Cyril led MSD's subsidiary in Canada. Cyril’s entire career has been international, first with Sanofi, then Schering-Plough and MSD. He held several executive roles in different geographies.
Cyril is a French national and holds an MBA and a master’s diploma in international business and marketing from the University of Paris-Dauphine.
Articles: Cyril Schiever
Vaccine Hesitancy and the Threat to Global Health Security
Vaccines / MSD’s Cyril Schiever outlines why vaccine hesitancy is such a threat to global health, the misinformation around vaccines being spread online, and how multi-stakeholder collaboration can help counter this emerging problem. The World Health Organization (WHO) recently identified vaccine hesitancy as one of the top 10 global health threats for 2019, alongside major health…
Latest Report
